Within the rapidly-expanding area of competition law and healthcare, public hospitals and state aid may seem at first a mundane topic when contrasted with developments in connection with pharmaceutical policy and health technology. Nevertheless, the CJEU’s April 2023 Casa Regina Apostolorum judgment has reignited fundamental questions about the very applicability of EU competition policy which have implications far beyond the case’s focus on the interaction between private providers and public hospitals, and state support to the latter, in Italy.
This post considers how the Casa Regina Apostolorum case fits within wider analysis of competition reforms in healthcare, and the tensions which now emerge between this judgment and the Commission’s Evaluation of the State Subsidy Rules for Health and Social Services of General Economic Interest which reported in December 2022.
Read the full blog post published on Ideas on Europe here